Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 22984204)

Published in J Antimicrob Chemother on September 14, 2012

Authors

Chao-Hung Kuo1, Ping-I Hsu, Fu-Chen Kuo, Sophie S W Wang, Huang-Ming Hu, Chung-Jung Liu, Seng-Kee Chuah, Yen-Hsu Chen, Ming-Chia Hsieh, Deng-Chyang Wu, Hui-Hwa Tseng

Author Affiliations

1: Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

Articles citing this

Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance. World J Gastroenterol (2014) 0.99

Second and third line treatment options for Helicobacter pylori eradication. World J Gastroenterol (2014) 0.93

Treatment of Helicobacter pylori infection: Current and future insights. World J Clin Cases (2016) 0.92

CYP2C19 polymorphism influences Helicobacter pylori eradication. World J Gastroenterol (2014) 0.83

The clinical and bacteriological factors for optimal levofloxacin-containing triple therapy in second-line Helicobacter pylori eradication. PLoS One (2014) 0.83

Antimicrobial activity of natural products against Helicobacter pylori: a review. Ann Clin Microbiol Antimicrob (2014) 0.80

Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan. Gastroenterol Res Pract (2013) 0.78

High efficacy of gemifloxacin-containing therapy in Helicobacter Pylori eradication: A pilot empirical second-line rescue therapy. Medicine (Baltimore) (2016) 0.77

Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection. Biomed Res Int (2015) 0.76

Does long-term use of silver nanoparticles have persistent inhibitory effect on H. pylori based on Mongolian gerbil's model? Biomed Res Int (2014) 0.75

Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection. World J Gastroenterol (2014) 0.75

Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication. Antimicrob Agents Chemother (2014) 0.75

Articles by these authors

Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells (2009) 4.08

Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell (2011) 3.83

Clinical characteristics and prognostic factors of splenic abscess: a review of 67 cases in a single medical center of Taiwan. World J Gastroenterol (2006) 2.41

Laboratory diagnostics of dengue fever: an emphasis on the role of commercial dengue virus nonstructural protein 1 antigen rapid test. J Microbiol Immunol Infect (2012) 2.32

Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol (2013) 2.16

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection. Clin Gastroenterol Hepatol (2009) 2.15

Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett (2005) 2.13

Standardization of intraoperative neuromonitoring of recurrent laryngeal nerve in thyroid operation. World J Surg (2010) 2.04

Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology (2005) 2.03

Urinary Mycobacterium szulgai infection in an immunocompetent patient. South Med J (2009) 2.02

Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding. Hepatology (2008) 1.95

Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic crypt fission, proliferation, and colorectal cancer in mice. J Clin Invest (2009) 1.90

Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr (2004) 1.83

Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc (2004) 1.81

A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. Am J Gastroenterol (2005) 1.79

Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer (2005) 1.78

Comparison of hemostatic efficacy for epinephrine injection alone and injection combined with hemoclip therapy in treating high-risk bleeding ulcers. Gastrointest Endosc (2006) 1.75

Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days. Helicobacter (2011) 1.73

Gastric cancer: preoperative local staging with 3D multi-detector row CT--correlation with surgical and histopathologic results. Radiology (2007) 1.66

The effects of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis. Gastrointest Endosc (2005) 1.63

A new look at anti-Helicobacter pylori therapy. World J Gastroenterol (2011) 1.59

Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J (2003) 1.58

Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions. Int J Antimicrob Agents (2012) 1.56

Role of genotype and precore/basal core promoter mutations of hepatitis B virus in patients with chronic hepatitis B with acute exacerbation. Scand J Gastroenterol (2008) 1.55

Endoscopic papillary balloon dilation for removal of bile duct stones: evaluation of outcomes and complications in 298 patients. J Clin Gastroenterol (2012) 1.55

Colorectal neoplasm in asymptomatic Asians: a prospective multinational multicenter colonoscopy survey. Gastrointest Endosc (2007) 1.55

Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents (2012) 1.54

Comparison of hemostatic efficacy for argon plasma coagulation and distilled water injection in treating high-risk bleeding ulcers. J Clin Gastroenterol (2009) 1.52

SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes. Diabetes (2007) 1.51

The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut (2011) 1.48

Effect of somatostatin in the prevention of pancreatic complications after endoscopic retrograde cholangiopancreatography. J Chin Med Assoc (2008) 1.46

Clinical effects of intra-arterial infusion chemotherapy with cisplatin, mitomycin C, leucovorin and 5-flourouracil for unresectable advanced hepatocellular carcinoma. J Chin Med Assoc (2004) 1.46

Computer laboratory notification system via short message service to reduce health care delays in management of tuberculosis in Taiwan. Am J Infect Control (2011) 1.44

Emergency endoscopic variceal ligation versus somatostatin for acute esophageal variceal bleeding. J Chin Med Assoc (2006) 1.41

Sphingomonas paucimobilis bacteremia in humans: 16 case reports and a literature review. J Microbiol Immunol Infect (2010) 1.37

Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: a 5·5-year prospective analysis. Eur J Clin Invest (2011) 1.36

Activating KRAS mutations and overexpression of epidermal growth factor receptor as independent predictors in metastatic colorectal cancer patients treated with cetuximab. Ann Surg (2010) 1.36

Short report: Abnormal liver function in scrub typhus. Am J Trop Med Hyg (2005) 1.31

Cyclooxygenase-2-deficient mice are resistant to endotoxin-induced inflammation and death. FASEB J (2003) 1.29

Endoscopic papillary large balloon dilation alone without sphincterotomy for the treatment of large common bile duct stones. BMC Gastroenterol (2011) 1.29

Impact of renal failure on the outcome of dengue viral infection. Clin J Am Soc Nephrol (2008) 1.28

Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol (2013) 1.25

Carcinogenetic impact of alcohol intake on squamous cell carcinoma risk of the oesophagus in relation to tobacco smoking. Eur J Cancer (2007) 1.23

Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid. Int J Cancer (2008) 1.21

Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days? Helicobacter (2011) 1.21

Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial. J Antimicrob Chemother (2009) 1.21

Clinical remission in endoscope-guided pneumatic dilation for the treatment of esophageal achalasia: 7-year follow-up results of a prospective investigation. J Gastrointest Surg (2009) 1.20

Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species. Antimicrob Agents Chemother (2011) 1.19

Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter study. Gastrointest Endosc (2012) 1.19

2011 update on esophageal achalasia. World J Gastroenterol (2012) 1.18

Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway. J Immunol (2005) 1.17

Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis. Int J Infect Dis (2010) 1.16

The decline of autophagy contributes to proximal tubular dysfunction during sepsis. Shock (2012) 1.15

Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett (2003) 1.15

Molecular characterisation of the metallo-beta-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan. Int J Antimicrob Agents (2008) 1.14

Dengue fever with acute acalculous cholecystitis. Am J Trop Med Hyg (2003) 1.14

Antimicrobial-resistant nocardia isolates, Taiwan, 1998-2009. Clin Infect Dis (2011) 1.14

Transient elastography and simple blood markers in the diagnosis of esophageal varices for compensated patients with hepatitis B virus-related cirrhosis. J Gastroenterol Hepatol (2012) 1.14

Interactive effects of lifetime alcohol consumption and alcohol and aldehyde dehydrogenase polymorphisms on esophageal cancer risks. Int J Cancer (2006) 1.13

The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Crit Care Med (2010) 1.12

Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis. World J Surg (2006) 1.11

Different impact from betel quid, alcohol and cigarette: risk factors for pharyngeal and laryngeal cancer. Int J Cancer (2005) 1.11

Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis. Infect Immun (2007) 1.10

Euphol from Euphorbia tirucalli selectively inhibits human gastric cancer cell growth through the induction of ERK1/2-mediated apoptosis. Food Chem Toxicol (2012) 1.10

Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels. Clin Cancer Res (2007) 1.10

Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. World J Gastroenterol (2005) 1.09

Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Ann Surg (2007) 1.09

Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience. J Gastroenterol Hepatol (2007) 1.08

Impact of low-residue diet on bowel preparation for colonoscopy. Dis Colon Rectum (2011) 1.08

Uterine lipoleiomyosarcoma: report of 2 cases and review of the literature. Int J Gynecol Pathol (2012) 1.08

Abdominal tuberculosis: analysis of clinical features and outcome of adult patients in southern Taiwan. Chang Gung Med J (2009) 1.08

Surveillance culture of endoscope to monitor the quality of high-level disinfection of gastrointestinal reprocessing. Hepatogastroenterology (2010) 1.07

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. Inflamm Bowel Dis (2010) 1.07

Caroli's disease - a report of two siblings. Eur J Gastroenterol Hepatol (2002) 1.07

Randomized controlled trial of monthly versus biweekly endoscopic variceal ligation for the prevention of esophageal variceal rebleeding. J Gastroenterol Hepatol (2014) 1.05

Why is in-hospital diagnosis of pulmonary tuberculosis delayed in southern Taiwan? J Formos Med Assoc (2010) 1.05

San-Huang-Xie-Xin-Tang inhibits Helicobacter pylori-induced inflammation in human gastric epithelial AGS cells. J Ethnopharmacol (2007) 1.05

Bilateral simultaneous facial palsy following scrub typhus meningitis: a case report and literature review. Kaohsiung J Med Sci (2011) 1.05

Mycobacterium chelonae empyema in an immunocompetent patient. J Med Microbiol (2008) 1.04

Endoscopic findings and management of dengue patients with upper gastrointestinal bleeding. Am J Trop Med Hyg (2005) 1.04

RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation. J Cell Physiol (2014) 1.04

Identification of a bone marrow-derived mesenchymal progenitor cell subset that can contribute to the gastric epithelium. Lab Invest (2009) 1.03

Evaluation of macrolide resistance and enhanced molecular typing of Treponema pallidum in patients with syphilis in Taiwan: a prospective multicenter study. J Clin Microbiol (2012) 1.03

Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas. Virchows Arch (2003) 1.03

Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2. Pathol Int (2006) 1.03

Acute hemorrhagic rectal ulcer syndrome: a new clinical entity? Report of 19 cases and review of the literature. Dis Colon Rectum (2004) 1.03

Primary cutaneous plasmacytosis successfully treated with topical photodynamic therapy. Acta Derm Venereol (2005) 1.03

Translocation of Helicobacter pylori CagA into Human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma. Cancer Res (2010) 1.02

Epidemiology of acute q Fever, scrub typhus, and murine typhus, and identification of their clinical characteristics compared to patients with acute febrile illness in southern taiwan. J Formos Med Assoc (2009) 1.02

Retroperitoneal enteric duplication cyst. J Chin Med Assoc (2004) 1.02

K-ras mutation targeted to gastric tissue progenitor cells results in chronic inflammation, an altered microenvironment, and progression to intraepithelial neoplasia. Cancer Res (2010) 1.02

Clinical features and prognostic factors of emphysematous urinary tract infection. J Microbiol Immunol Infect (2009) 1.02

One-week quadruple therapy is an effective salvage regimen for Helicobacter pylori infection in patients after failure of standard triple therapy. J Clin Gastroenterol (2002) 1.02